Wilson Sonsini Goodrich & Rosati is representing LENZ Therapeutics in the transaction, Goodwin Procter is representing Graphite Bio and Latham & Watkins is representing the placements...
LENZ Therapeutics’ Merger with Graphite Bio
C4 Therapeutics’ Exclusive Licensing Agreement with Betta Pharmaceuticals
Goodwin Procter served as legal counsel to C4T, and Han Kun Law Offices served as legal counsel to Betta. C4 Therapeutics, Inc. announced its exclusive licensing agreement...
HqO’s Acquisition of Leesman
Goodwin advised HqO on the deal. HqO announced its acquisition of Leesman. HqO is an industry leading tenant and workplace experience platform transforming how people connect with...
Thermo Fisher Scientific’s Investment in Ionpath
Goodwin Procter advised Ionpath, Inc. on the deal. Thermo Fisher Scientific announced its strategic investment in Ionpath, Inc. Ionpath, Inc., based in Menlo Park, California, is a...
HqO’s Acquisition of Office App
Goodwin Procter advised HqO on the deal. HqO, the end-to-end tenant experience platform for commercial real estate properties, announced its acquisition of Office App, a leading European...
AbCellera’s Acquisition of TetraGenetics
Goodwin Procter advised AbCellera on the deal. AbCellera (Nasdaq: ABCL) announced its acquisition of TetraGenetics. AbCellera is a technology company with a centralized operating system for next-generation...
Better Therapeutics’ $187 Million Merger Agreement with Mountain Crest Acquisition Corp II
Goodwin Procter LLP advised Better Therapeutics, Inc. on the deal. Better Therapeutics, Inc. announced its definitive merger agreement with Mountain Crest Acquisition Corp II (Nasdaq: MCAD;), a...
Coridea’s Collaboration with Deerfield Management Company
Goodwin Procter LLP advised Coridea on the deal. Coridea announced its collaboration with Deerfield Management Company, named Deerfield Device Design and Development Catalyst, to advance medtech innovation...